future glp-1 drugs Antagonists Increase Plan Drug Spend - What's Next Didn't take much for the

December 5, 2023 Zepbound Released to Market A month after getting FDA approval, Zepbound was released to market and available at retail and mail-order pharmacies

Clinical guidelines are expanding to recommend GLP-1 therapies for this group, supported by evidence showing effective weight loss and metabolic benefits at this stage

However, unlike FDA-approved GLP-1 medications, these patches arent regulated to the same public safety standards, and the claims made by manufacturers are not backed by the same degree of rigorous clinical trials

Burgmaier M, Heinrich C, Marx N

In the context of DR, this leads to the phosphorylation of ERK1/2, increasing downstream expression of anti-apoptotic genes like BCL2 and reducing the activity of pro-apoptotic markers such as Caspase-3